Biotech

Biotech & Healthcare News

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 01.02.2022.

Clinical research
Antibody
Beta amyloid
Policy
Strategic management
Initial public offering

Healthcare

@CR_UK shared
On Jan 27, 2022
Latest findings from the CAPTURE study provides the first data on Omicron response after vaccination in people with cancer. Read more 👇 https://t.co/kVCmx9xYYr
Open
COVID-19 vaccine and cancer – latest updates

COVID-19 vaccine and cancer – latest updates

Recently, news of a COVID-19 vaccine has dominated headlines. We've summarised all the information that is out there, with rolling updates, in our new vaccine blog post.

@DrugInfoAssn shared
On Jan 26, 2022
We are so excited to announce our lineup of experts and featured speakers at DIA’s 2022 Virtual Latin America Regulatory Conference! Register by **February 11** for Early Bird pricing. https://t.co/mLQASjx7jn https://t.co/mEUdSpRAX7
Open
@BIODeutschland shared
On Jan 31, 2022
RT @CTIClinical: Check out the feature in the @NKyTribune, co-written by our Chairman and CEO Tim Schroeder alongside @GravityCLIALab and @BexionPharma. #movingmedicineforward https://t.co/FkOpYWKKTg
Open
Legislators can ‘help us change world,’ say experts; ‘R&D lab critical to attracting biotech startups’

Legislators can ‘help us change world,’ say experts; ‘R&D lab critical to attracting biotech startups’

By Tony Remington, Gravity Diagnostics, Tim Schroeder, CTI, and Ray Takigiku, Bexion Special to NKyTribune With a single investment, the Kentucky General Assembly has an …

@JNJInnovation shared
On Jan 31, 2022
“Despite the ongoing challenges of the pandemic, science & innovation have continued to march forward.” In 2021, JJDC continued to invest in & support new ideas to change the trajectory of human health. Learn more & stay connected: https://t.co/bepNDyR0sa https://t.co/jwhGoEeD0r
Open
IPOs on the Rise for Life Sciences and Biotech

IPOs on the Rise for Life Sciences and Biotech

NewCo Creation will work with colleagues across Johnson & Johnson and the broader life science ecosystem to create and launch innovative solutions to meet critical unmet needs – …

@DrugInfoAssn shared
On Jan 27, 2022
Change is here; don’t get left behind! Co-Founder and CEO of Well Played, Gautam Gulati, MD, MBA, MPH will deliver his Keynote Address: How to Think Like an Innovator in a World of Uncertainty. Learn more at https://t.co/GqB8VnHAX2 #RSIDM22 https://t.co/2JwUGizKBI
Open
@matthewherper shared
On Feb 1, 2022
RT @statesdj: @matthewherper Let’s not forget how NIH study section capture set the stage for aduhelm https://t.co/qinUhRPLuR
Open
The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades

The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades

This stifling of competing ideas, say a growing number of scholars, is a big reason why there is no treatment for Alzheimer’s.